Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Ramagopal, Udupi A UA; Liu, Weifeng W; Garrett-Thomson, Sarah C SC; Bonanno, Jeffrey B JB; Yan, Qingrong Q; Srinivasan, Mohan M; Wong, Susan C SC; Bell, Alasdair A; Mankikar, Shilpa S; Rangan, Vangipuram S VS; Deshpande, Shrikant S; Korman, Alan J AJ; Almo, Steven C SC